Literature DB >> 35779196

Aging Promotes Chronic Stress-Induced Depressive-Like Behavior by Activating NLRP1 Inflammasome-Driven Inflammatory Signaling in Mice.

Ya-Jing Zhu1, Jun-Juan Fan1,2, Fang-Yi Wu1, Ming Zhang1, Ao-Qi Song1, Yong Li1, Yan-Kun Li3, Wen-Ning Wu4.   

Abstract

NLRP1 inflammasome has been reported to participate in many neurological disorders. Our previous study has demonstrated that NLRP1 inflammasome is implicated in chronic stress-induced depressive-like behaviors in mice. Age has been reported to be related to depression. Here we examine whether NLRP1 inflammasome is involved in the effect of age on depressive disorder. Two chronic stress stimuli, chronic social defeat stress (CSDS) and repeat social defeat stress (RSDS), were used to establish a depression model in mice of different ages. We found that aged mice exhibited worse depressive-like behaviors and locomotor activity compared to young mice. Interestingly, the expression of hippocampal NLRP1 inflammasome complexes and the levels of the inflammatory cytokines were increased in an age-dependent manner. Also, chronic stress-induced increase in the expression of the hippocampal chemokine C-X-C motif ligand 1 (CXCL1), and its cognate receptor, CXC-motif receptor 2 (CXCR2), was more remarkable in aged mice than that in young mice. Moreover, aged mice exhibited lower hippocampal BDNF levels compared to young mice. Hippocampal Nlrp1a knockdown reduced the levels of pro-inflammatory cytokines and the expression of CXCL1/CXCR2, restored BDNF levels, and alleviated chronic stress-induced depressive-like behaviors in aged mice. Our results suggest that NLRP1 inflammasome-CXCL1/CXCR2-BDNF signaling contributes to the effect of age on chronic stress-induced depressive-like behavior in mice.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  BDNF.; CXCL1; NLRP1 inflammasome; age; depression

Year:  2022        PMID: 35779196     DOI: 10.1007/s10753-022-01683-4

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  38 in total

Review 1.  The role of inflammation in depression: from evolutionary imperative to modern treatment target.

Authors:  Andrew H Miller; Charles L Raison
Journal:  Nat Rev Immunol       Date:  2016-01       Impact factor: 53.106

Review 2.  A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity.

Authors:  Sarah A Hiles; Amanda L Baker; Theo de Malmanche; John Attia
Journal:  Brain Behav Immun       Date:  2012-06-09       Impact factor: 7.217

Review 3.  Signaling pathways underlying the rapid antidepressant actions of ketamine.

Authors:  Ronald S Duman; Nanxin Li; Rong-Jian Liu; Vanja Duric; George Aghajanian
Journal:  Neuropharmacology       Date:  2011-09-02       Impact factor: 5.250

4.  A meta-analysis of cytokines in major depression.

Authors:  Yekta Dowlati; Nathan Herrmann; Walter Swardfager; Helena Liu; Lauren Sham; Elyse K Reim; Krista L Lanctôt
Journal:  Biol Psychiatry       Date:  2009-12-16       Impact factor: 13.382

Review 5.  Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.

Authors:  M Bryant Howren; Donald M Lamkin; Jerry Suls
Journal:  Psychosom Med       Date:  2009-02-02       Impact factor: 4.312

Review 6.  Treatment of bipolar disorder.

Authors:  John R Geddes; David J Miklowitz
Journal:  Lancet       Date:  2013-05-11       Impact factor: 79.321

Review 7.  Inflammation in Depression and the Potential for Anti-Inflammatory Treatment.

Authors:  Ole Kohler; Jesper Krogh; Ole Mors; Michael Eriksen Benros
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

Review 8.  Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets.

Authors:  Ji-Chun Zhang; Wei Yao; Kenji Hashimoto
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

9.  Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder.

Authors:  C D Rethorst; M S Toups; T L Greer; P A Nakonezny; T J Carmody; B D Grannemann; R M Huebinger; R C Barber; M H Trivedi
Journal:  Mol Psychiatry       Date:  2012-08-28       Impact factor: 15.992

10.  Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010.

Authors:  Alize J Ferrari; Fiona J Charlson; Rosana E Norman; Scott B Patten; Greg Freedman; Christopher J L Murray; Theo Vos; Harvey A Whiteford
Journal:  PLoS Med       Date:  2013-11-05       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.